RH133031 |
Tris(2,4-di-tert-butylphenyl)phosphate |
Tris(2,4-di-tert-butylphenyl)phosphate is an active compound from the leaves of
|
RH133032 |
BPK-29 hydrochloride |
BPK-29 hydrochloride is a specific ligand that disrupts the atypical orphan nucl
|
RH133033 |
Pentamidine |
Pentamidine (MP-601205) is an antimicrobial agent and interferes with DNA biosyn
|
RH133034 |
Licochalcone A |
Licochalcone A (LCA), a flavonoid isolated, presents obvious anti-cancer effects
|
RH133035 |
Dexrazoxane |
Dexrazoxane, as an intracellular iron chelating agent, reduces the formation of
|
RH133036 |
Emtricitabine |
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC5
|
RH133037 |
GPS491 |
GPS491 (EC50 = 0.47 μM) suppresses expression of the HIV-1 structural protein Ga
|
RH133038 |
TTBK1-IN-2 |
TTBK1-IN-2 (compound 29) is a potent Tau-Tubulin kinase (TTBK1) inhibitor with I
|
RH133039 |
somatostatin |
Somatostatin
|
RH133040 |
Sodium houttuyfonate |
Sodium Houttuyfonate
|
RH133041 |
retro-Methyl-a-ionol |
retro-Methyl-α-ionol
|
RH133042 |
Isocarboxazid |
Isocarboxazid is a non-selective and irreversible inhibitor of monoamine oxidase
|
RH133043 |
Vimseltinib |
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted fr
|
RH133044 |
Phentolamine Mesylate |
Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selec
|
RH133045 |
CW 008 |
CW 008, a derivative of pyrazole-pyridine, is a CREB or PKA pathway agonist.
|
RH133046 |
Ilginatinib |
Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor,
|
RH133047 |
Ilginatinib hydrochloride |
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally b
|
RH133048 |
Trandolapril |
Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the act
|
RH133049 |
VLX600 |
VLX600 is an iron-chelating inhibitor of oxidative phosphorylation (OXPHOS).
|
RH133050 |
Tirbanibulin Mesylate |
Tirbanibulin Mesylate (KX2-391 Mesylate) is an inhibitor of Src that targets the
|